Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 2 (KIR2DL2) antibody

Details for Product No. ABIN234532
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms NKAT6, p58.2, CD158b, CD158B1
Reactivity
Human
(13)
Host
Mouse
(10), (3)
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
(1), (1), (1), (1), (1), (1)
Application
Immunoprecipitation (IP), Flow Cytometry (FACS)
(11), (10), (7), (1), (1), (1), (1), (1)
Pubmed 8 references available
Quantity 0.2 mg
Options
Shipping to United States (Change)
Availability Will be delivered in 4 to 5 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN234532
450.27 $
Plus shipping costs $45.00

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen NK cell clone E57 (CD2+, CD3-, CD7+, CD16+, CD56+)
Clone GL183
Isotype IgG1
Specificity GL183 monoclonal antibody immunoprecipitates the p58.2 molecule, a 58 kDa type I transmembrane protein (1-3). It can also react with a lighter (p50.2, 58 kDa) molecule, highly homologous to p58.2 in the extracellular area, but exhibiting a shorter cytoplasmic tail.(4,5) These p58.2 and 50.2 molecules are characterized by two immunoglobulin-like extracellular domains. They are expressed by human NK cell subsets and by human T lymphocytes subsets, the latest being, in most instances, CD8+CD4-TCR alpha beta+.(6,7) p58.2 and p50.2 are members of the newly described natural killer cell receptor (NK-R) family (for reviews, see 8,9). The GL183 antibody can restore in vitro the lysis by human NK clones of otherwise lysis-protected targets carrying the Cw3 or related alleles. GL183 antibody has been assigned to the CD158b cluster of differentiation of the VIth International Workshop on Human Leucocyte Differentiation Antigens (HLDA) in Kobe, 1996.
Characteristics MAb to Human CD158b (p58.2), Monoclonal antibody to Human CD158b (p58.2)
Purification Protein A Chromatography. Ascites
Alternative Name CD158b (p58.2)
Application Notes Flow cytometry: 2 µg / 5 x 105 cells (or 100 µL whole blood), per test. Studies on the recognition mechanisms and function of NK cells and CTLs. Analysis of the NK cell repertoire. Immunoprecipitation of p50.2 and p58.2 molecules. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Reconstitute with 1 mL distilled water.
Concentration 0.2 mg/mL (prior to lyophilization)
Buffer Lyophilized from PBS containing 1 mg/mL BSA.
Preservative Without preservative
Handling Advice Avoid multiple freeze/thaw cycles. The addition of 0.1 % (w/v) sodium azide is recommended for storage of the Reconstituted liquid for up to one month at 2-8 °C.
Centrifuge product if not completely clear after standing at room temperature.
Prepare working dilution only prior to immediate use.
Storage 4 °C/-20 °C
Storage Comment Store lyophilized product at 2-8 °C. After reconstitution, aliquot and store at -28 °C.
General Moretta, Tambussi, Bottino et al.: "A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function." in: The Journal of experimental medicine, Vol. 171, Issue 3, pp. 695-714, 1990 (PubMed).

Moretta, Bottino, Pende et al.: "Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition." in: The Journal of experimental medicine, Vol. 172, Issue 6, pp. 1589-98, 1991 (PubMed).

Moretta, Sivori, Vitale et al.: "Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells." in: The Journal of experimental medicine, Vol. 182, Issue 3, pp. 875-84, 1995 (PubMed).

Wagtmann, Biassoni, Cantoni et al.: "Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains." in: Immunity, Vol. 2, Issue 5, pp. 439-49, 1995 (PubMed).

Ferrini, Cambiaggi, Meazza et al.: "T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function." in: European journal of immunology, Vol. 24, Issue 10, pp. 2294-8, 1994 (PubMed).

Biassoni, Cantoni, Falco et al.: "The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions." in: The Journal of experimental medicine, Vol. 183, Issue 2, pp. 645-50, 1996 (PubMed).

Mingari, Schiavetti, Ponte et al.: "Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, Issue 22, pp. 12433-8, 1996 (PubMed).

Lanier: "Natural killer cell receptors and MHC class I interactions." in: Current opinion in immunology, Vol. 9, Issue 1, pp. 126-31, 1997 (PubMed).

Validation Images
Did you look for something else?
back to top